GlassScriptPhysician profile
Ashley Erin Mason
NPI 1871735100
$2,702.64
in general payments reported to CMS, 2019-2025
24 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $347 · 2021: $897 · 2022: $569 · 2023: $287 · 2024: $117 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.37 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,120.96 | 2019-2024 | |
| Pfizer INC. | $229.58 | 2019-2024 | |
| Exeltis, USA INC. | $192.65 | 2020-2025 | Slynd |
| Organon LLC | $169.55 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $129.82 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.37 | 2019-2024 | |
| Ethicon US, LLC | $122.28 | 2019-2021 | |
| Astellas Pharma US INC | $118.46 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $90.90 | 2023-2025 | Fluent Fluid Management System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Mylan Pharmaceuticals INC. | $58.86 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $56.46 | 2019-2021 | |
| Therapeuticsmd, INC. | $52.15 | 2019-2022 | |
| Millicent US INC | $39.50 | 2025 | Femlyv, Intrarosa |
| Roche Diagnostics Corporation | $33.92 | 2019 | |
| Allergan, INC. | $26.36 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $25.47 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $14.56 | 2019 | |
| Meditrina | $14.40 | 2022 | |
| Boston Scientific Corporation | $14.09 | 2019 | |
| Sumitomo Pharma America, INC. | $13.71 | 2025 | Myfembree |
| Avion Pharmaceuticals | $12.97 | 2022 | |
| Myovant Sciences INC. | $12.94 | 2022 | |
| Channel Medsystems, INC. | $12.03 | 2023 | |
| Amag Pharmaceuticals, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.